Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRO
CRO
Longtime Charles River CEO to retire; COO will take the helm
After more than 30 years as president and CEO, Jim Foster plans to retire from the CRO giant on May 5, with COO Birgit Girshick taking his place.
Darren Incorvaia
Jan 8, 2026 12:54pm
Breast cancer tops list of most-studied diseases in 2025
Dec 30, 2025 5:00am
Lindus and Quotient team up to create one-stop shop for trials
Dec 17, 2025 2:35pm
JSR hands over Crown to Carlyle-backed company in $204M deal
Nov 18, 2025 2:32pm
Charles River lays off 70 staffers as strategic shift begins
Nov 14, 2025 4:40pm
Thermo Fisher to buy Clario in $9B deal
Oct 31, 2025 12:41pm
